Parisa Salehi, MD

"I believe in working as a team to best care for children and young adults with complex medical needs. I love bringing up-to-date, comprehensive care to patients using research and inter-disciplinary collaboration. "

  • Dr. Salehi received her BS in biology from the University of California, Riverside in 2003. She then went on to receive her MD from University of Nevada School of Medicine in 2017. She did her pediatric training at Children's Hospital Orange County in Orange, CA from 2007-2010 and her pediatric endocrine training at Children's Hospital Los Angeles, Los Angeles, CA from 2010-2013. She joined Seattle Children's Hospital as faculty in the Department of Pediatrics, Division of Endocrinology in 2013. She has been Clinical Director of the Prader-Willi Syndrome Clinic at Seattle Children's Hospital since 2014. She has been part of the Seattle Children's Gender Clinic since 2017. 

    • Sarah Bellingham, WA 01.28.16

      My daughter is 10 years old and was diagnosed about 1 1/2 years ago with T1D, Dr. Salehi and and Seattle Children's hospital have both been great. Dr. Salehi is very sweet to my daughter and is very helpful when we have any questions.

    • Jane Seattle WA 01.15.15

      My daughter has been seeing Dr. Salehi for the past year and a half. My daughter, at 10, is an active participant in her health care and appreciates knowing a lot about what is going on. I am grateful for Dr. Salehi's wonderful way with my daughter. She is very knowledgable about my daughter's treatment, listens well and explains things very clearly to us both. I appreciate her responsiveness when I have had questions or concerns outside of clinic as well.

  • Award Name Award Description Awarded By Award Date
    Presidential Poster Competition Award Endocrine Society June 2013
  • Other Publications

    • Salehi P, Roberts AJ, Kim GJ
      Efficacy and Safety of Real Life Usage of MiniMed 670G Automode in Children with Type 1 Diabetes Less than 7 Years Old.
      31166801 Diabetes technology & therapeutics, 2019 Jun 5
    • Duis J, van Wattum PJ, Scheimann A, Salehi P, Brokamp E, Fairbrother L, Childers A, Shelton AR, Bingham NC, Shoemaker AH, Miller JL
      A multidisciplinary approach to the clinical management of Prader-Willi syndrome.
      30697974 Molecular genetics & genomic medicine, 2019 March : 7(3)e514 PMCID:PMC6418440
    • Inwards-Breland DJ, DiVall S, Salehi P, Crouch JM, Negaard M, Lu A, Kantor A, Albertson K, Ahrens KR
      Youth and Parent Experiences in a Multidisciplinary Gender Clinic.
      30949585 Transgender health, 2019 : 4(1)100-106 PMCID:PMC6447995
    • Salehi P, Herzig L, Capone G, Lu A, Oron AP, Kim SJ
      Comparison of Aberrant Behavior Checklist profiles across Prader-Willi syndrome, Down syndrome, and autism spectrum disorder.
      30575291 American journal of medical genetics. Part A, 2018 Dec. : 176(12)2751-2759
    • Salehi P, Lee D, Ambartsumyan L, Sikka N, Scheimann AO
      Rectal Picking Masquerading as Inflammatory Bowel Disease in Prader-Willi Syndrome.
      29470292 Journal of pediatric gastroenterology and nutrition, 2018 July : 67(1)59-63
    • Salehi P, Divall SA, Crouch JM, Hopkinson RA, Kroon L, Lawrence J, Wilfond BS, Inwards-Breland DJ
      Review of Current Care Models for Transgender Youth and Application to the Development of a Multidisciplinary Clinic - The Seattle Children's Hospital Experience.
      29806748 Pediatric endocrinology reviews : PER, 2018 April : 15(4)280-290
    • McCandless SE, Yanovski JA, Miller J, Fu C, Bird LM, Salehi P, Chan CL, Stafford D, Abuzzahab MJ, Viskochil D, Barlow SE, Angulo M, Myers SE, Whitman BY, Styne D, Roof E, Dykens EM, Scheimann AO, Malloy J, Zhuang D, Taylor K, Hughes TE, Kim DD, Butler MG
      Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.
      28556449 Diabetes, obesity & metabolism, 2017 Dec. : 19(12)1751-1761 PMCID:PMC5673540
    • Salehi P, Stafford HJ, Glass RP, Leavitt A, Beck AE, McAfee A, Ambartsumyan L, Chen M
      Silent aspiration in infants with Prader-Willi syndrome identified by videofluoroscopic swallow study.
      29390364 Medicine, 2017 Dec. : 96(50)e9256 PMCID:PMC5815776
    • Dickerson JA, Polsky TG, Greene DN, Salehi P, Roberts AJ, Jack RM
      False-Positive Total T3 Using the Ortho Vitros Immunoassay in Pediatric Populations
      The Journal of Applied Laboratory Medicine, 2017 May : 1(6)751-753
    • Olney RC, Salehi P, Prickett TC, Lima JJ, Espiner EA, Sikes KM, Geffner ME
      Dynamic response of C-type natriuretic peptide and its aminoterminal propeptide (NTproCNP) to growth hormone treatment in children with short stature.
      27177682 Clinical endocrinology, 2016 Oct. : 85(4)561-8
    • Salehi P, Hsu I, Azen CG, Mittelman SD, Geffner ME, Jeandron D
      Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome
      Pediatr Obes, 2016
    • Salehi P, Leavitt A, Beck AE, Chen ML, Roth CL
      Obesity management in Prader-Willi syndrome.
      25962207 Pediatric endocrinology reviews : PER, 2015 March : 12(3)297-307
    • Miller B, Salehi P, Shih E, Vedin A
      2012 Annual Meeting of Pediatric Endocrine Society. Selected highlights. Boston, Massachusetts (April 27-May 1, 2012).
      23304811 Pediatric endocrinology reviews : PER, 2012 Aug. : 9(4)734-43
    • Austin J, Franklin S, Pitukcheewanont P, Salehi P, Vedin A
      Meeting highlights: Lawson Wilkins Pediatric Endocrine Society, Denver, Colorado, USA. April 30 - May 3, 2011.
      22397144 Pediatric endocrinology reviews : PER, 2011 Dec. : 9(2)598-608
    • Salehi P, Koh CJ, Pitukcheewanont P, Trinh L, Daniels M, Geffner M
      Persistent Müllerian duct syndrome: 8 new cases in Southern California and a review of the literature.
      23539834 Pediatric endocrinology reviews : PER, 10(2)227-33
  • Presentations Title Event Location Date
    Insatiable: Understanding Prader-Willi Syndrome, a Unique Phenotype of Obesity 1st International Pediatric Precision Medicine Forum Shanghai, China 2016
    Aberrant Behavior Checklist Scores in Children with Prader-Willi Syndrome compared to those with Autism 9th IPWSO Conference Toronto, Canada July 2016
    Silent Aspiration in Infants with Prader-Willi Syndrome identified by Videofluoroscopic Swallow Study European Society for Pediatric Endocrinology Annual Meeting Paris, France 2016
    How to Access and Benefit from Medical Clinics Prader-Willi Syndrome Association USA National Conference 2015 Orlando, FL 2015
    An Endocrine Review of Prader-Willi Syndrome, a Unique Phenotype of Obesity PEARL (Pediatric Endocrinology Association for Research and Learning) Seattle, WA 2015
    Panhypopituitarism in Youth MAGIC Foundation Conference Chicago, Illinois Jun 20, 2012
  • Grant Title Grantor Amount Award Date
    A Phase 2b/3 study to evaluate the safety, tolerability, and effects of Livoletide (AZP-531), an unacylated ghrelin analog, on food-related behaviors in patients with Prader-Willi syndrome Millendo Therapeutics US, Inc. March 2019
    A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients with Prader-Willi Syndrome Soleno Therapeutics, Inc. 2018


Board Certification(s)

Pediatric Endocrinology

Medical/Professional School

University of Nevada School of Medicine-Reno, Reno, NV


Children's Hospital of Orange County, Orange, CA


Children's Hospital of Los Angeles, Los Angeles, CA

Clinical Interests

Prader-Willi Syndrome

Gender Dysphoria


General Endocrinology 

Research Description

Dr. Salehi's main research interests are related to Prader-Willi Syndrome as well as Gender Dysphoria. She has participated in both local research efforts as well as national drug trials. 

Research Focus Area

Prader-Willi Syndrome, Gender Dysphoria